Zdrowie i gospodarka · 05/09/2023

FDA Releases Final Guidance for NTM-PD Treatment Drug Development

The Food and Drug Administration (FDA) has released a final guidance for the development of drugs to treat nontuberculous mycobacterial pulmonary disease (NTM-PD) caused by Mycobacterium avium complex (MAC), following a draft guidance issued on September 29, 2021.